Guselkumab Benefits Ulcerative Colitis Regardless of Patient

New QUASAR analysis shows patients with intolerance or failed response to advanced therapies nonetheless achieved benefit with guselkumab.

Related Keywords

Vancouver , British Columbia , Canada , Linkedin Brian Bressler , Brian Bressler , American College Of Gastroenterology , American College , Scientific Meeting , Pacg , Acg 2023 , Guselkumab , Ulcerative Colitis , Uc , Quasar , Phase 3 , Benefits ,